Wow. They have apparently abandoned any pretense of IV / sepsis efficacy now.
US commercialisation -- for an antiseptic spray -- is now 2028, at best?!
Not a mention of burns trial.
This is the one of the saddest things I have ever read.
And these dodgy results in P2 ABSSSI - not even a 50% cure rate. Is that enough to even warrant P3?!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
30.0¢ |
Change
0.005(1.69%) |
Mkt cap ! $86.51M | |||
| Open | High | Low | Value | Volume |
| 29.0¢ | 30.0¢ | 29.0¢ | $37.22K | 127.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 8471 | 29.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 30.0¢ | 17050 | 2 |
View Market Depth
| Last trade - 16.10pm 20/06/2025 (20 minute delay) ? |
| RCE (ASX) Chart |